– the leading provider of online annual reports to individual and institutional investors.

Halozyme Therapeutics, Inc.

Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports